Kelly Schoenbeck, MD

Title(s)Assistant Professor, Medicine
SchoolSchool of Medicine
ORCID ORCID Icon0000-0002-2408-6836 Additional info
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    Dr. Schoenbeck is a hematologist who studies clinical outcomes in patients with hematologic malignancies with a focus on health-related quality of life in chronic myeloid neoplasms.

    Collapse Biography 
    Collapse awards and honors
    American Society of Hematology2021  - 2022Research Training Award for Fellows, Year 2
    American Society of Hematology2021  - 2022Award Supplement
    American Society of Hematology 2020  - 2021Research Training Award for Fellows
    UCSF Hematology & Oncology Fellowship Program2018Rachel Pearline Award
    Columbia University Internal Medicine Residency Program2014Resident of the Month
    Oregon Health and Science University (OHSU)2011Gold Humanism Honor Society

    Collapse Research 
    Collapse Featured Publications
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Adverse events, quality of life, and work impairment in patients with chronic myeloid leukemia (CML)-a survey of first- and second-line tyrosine kinase inhibitor (TKI) intolerance in the US. Leuk Lymphoma. 2026 Sep 13; 1-11. Schoenbeck K, Wei D, Hazra NC, Constantinescu C, Meng Y, Latremouille-Viau D, Marquez G, Yang D, Damon A, Sadek I, Guérin A, Clements J, DeMairo K, Hiller J, Flynn KE. PMID: 42732478.
      View in: PubMed   Mentions:
    2. HSR25-174: Impact of Adverse Events on Quality of Life in Patients With Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors - Results From the Survey on Humanistic Burden of Intolerance to First or Second TKIs (SHIFT) Study. J Natl Compr Canc Netw. 2025 Mar 28; 23(3.5). Flynn KE, Clements J, DeMairo K, Hiller J, Wei D, Hazra NC, Constantinescu C, Meng Y, Latremouille-Viau D, Jadhav K, Marquez G, Yang D, Damon A, Sadek I, Guérin A, Schoenbeck K. PMID: 40154325.
      View in: PubMed   Mentions:    Fields:    
    3. HSR25-182: Patient-Physician Communication About Adverse Events and Impact on Quality of Life to Foster Shared Decision-Making in Chronic Myeloid Leukemia. J Natl Compr Canc Netw. 2025 Mar 28; 23(3.5). Flynn KE, Clements J, DeMairo K, Hiller J, Wei D, Hazra NC, Constantinescu C, Meng Y, Latremouille-Viau D, Jadhav K, Marquez G, Yang D, Damon A, Sadek I, Guérin A, Schoenbeck K. PMID: 40154303.
      View in: PubMed   Mentions:    Fields:    
    4. Frailty measures in multiple myeloma: evaluating the impact on outcomes and quality-of-life in clinical trials and real-world practice. Leuk Lymphoma. 2025 Feb; 66(2):190-203. Pianko MJ, Mian HS, Schoenbeck KL, Wildes TM. PMID: 39463423.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    5. Value of embedded palliative care: outpatient palliative care and health care utilization for patients with hematologic malignancies. Blood Adv. 2023 07 11; 7(13):3146-3149. Tsang M, Bischoff K, Schoenbeck KL, Berry K, O'Riordan D, Fakhri B, Wong SW, Shah N, Olin R, Andreadis C, Vieaux J, Cohen E, Lopez NS, Mannis GN, Rabow M. PMID: 36809787; PMCID: PMC10362539.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    6. Where the Sidewalk Ends: Parenting as a Trainee during COVID-19. Cancer Invest. 2023 Jul; 41(6):559-567. Tsang M, Banerjee R, Quiroga D, Idossa D, Schoenbeck KL. PMID: 37243573.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    7. Refining frailty in relapsed or refractory multiple myeloma: adding the patient voice. Lancet Healthy Longev. 2022 09; 3(9):e579-e580. Schoenbeck KL, Wildes TM. PMID: 36102770.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. Patient-Reported Functional Outcomes in Patients With Chronic Myeloid Leukemia After Stopping Tyrosine Kinase Inhibitors. J Natl Cancer Inst. 2022 01 11; 114(1):160-164. Schoenbeck KL, Atallah E, Lin L, Weinfurt KP, Cortes J, Deininger MWN, Kota V, Larson RA, Mauro MJ, Oehler VG, Pinilla-Ibarz J, Radich JP, Schiffer CA, Shah NP, Silver RT, Thompson JE, Flynn KE. PMID: 34491344; PMCID: PMC8755495.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    9. Being Present 2.0: Online Mindfulness-Based Program for Metastatic Gastrointestinal Cancer Patients and Caregivers. Glob Adv Health Med. 2021; 10:21649561211044693. Dragomanovich HM, Dhruva A, Ekman E, Schoenbeck KL, Kubo A, Van Blarigan EL, Borno HT, Esquivel M, Chee B, Campanella M, Philip EJ, Rettger JP, Rosenthal B, Van Loon K, Venook AP, Boscardin C, Moran P, Hecht FM, Atreya CE. PMID: 35174001; PMCID: PMC8842457.
      View in: PubMed   Mentions: 9  
    10. Health-Related Quality of Life of Patients with Chronic Myeloid Leukemia as Measured by Patient-Reported Outcomes: Current State and Future Directions. Curr Hematol Malig Rep. 2021 12; 16(6):491-499. Schoenbeck KL, Flynn KE. PMID: 34648119.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    11. Bortezomib in first-line therapy is associated with falls in older adults with multiple myeloma. J Geriatr Oncol. 2021 09; 12(7):1005-1009. Schoenbeck KL, Fiala MA, Wildes TM. PMID: 33750674; PMCID: PMC8419206.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    12. Circumstances around falls in older adults with Cancer. J Geriatr Oncol. 2021 01; 12(1):91-95. Tomczak U, Sattar S, Schoenbeck KL, Cordner T, Wildes TM. PMID: 32576521.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    13. Updated Perspectives on the Management of Multiple Myeloma in Older Patients: Focus on Lenalidomide. Clin Interv Aging. 2020; 15:619-633. Schoenbeck KL, Wildes TM. PMID: 32440105; PMCID: PMC7210019.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    14. Advance care planning and end-of-life care for patients with hematologic malignancies who die after hematopoietic cell transplant. Bone Marrow Transplant. 2017 06; 52(6):929-931. Eckhert EE, Schoenbeck KL, Galligan D, McNey LM, Hwang J, Mannis GN. PMID: 28287642.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    Kelly's Networks
    Concepts (43)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (13)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-40-gb10dcd06 on PROFILES-PWEB04.

    Copyright © The Regents of the University of California.